©The Author(s) 2026.
World J Clin Cases. Feb 6, 2026; 14(4): 117573
Published online Feb 6, 2026. doi: 10.12998/wjcc.v14.i4.117573
Published online Feb 6, 2026. doi: 10.12998/wjcc.v14.i4.117573
Figure 1 Line graph showing liver enzyme trend following the initiation and cessation of cefepime.
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase.
- Citation: Garcia R, English K. Mixed hepatocellular-cholestatic liver injury from cefepime: A case report. World J Clin Cases 2026; 14(4): 117573
- URL: https://www.wjgnet.com/2307-8960/full/v14/i4/117573.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i4.117573